Scientists comment on the risks and benefits of tirzepatide (Mounjaro) after a UK death linked to the drug. Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary Consultant, University of ...

Pharmaceutical giants Novartis, AbbVie and Lilly are also part of the CIC. "We built so much enthusiasm for collaborative research and sharing ideas through virtual meetings that we wanted to keep the ...

Even a juggernaut like Eli Lilly ( LLY 2.71%) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat ...

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

Chemists synthesized a highly complex natural molecule through a revolutionary strategy of functionalizing normally inert carbon-hydrogen ...

DelveInsight's Respiratory Disease Testing Market Insights report provides the current and forecast market analysis, individual ...

Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide ...

Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.

Awareness among Younger Generation Higher about Benefits of Timely Sarcopenia Treatment InterventionRockville, MD, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The world population has crossed 8 billion, with a ...

In 2023, Aditum’s weight loss biotech Versanis Bio sold to Eli Lilly for up to $1.92 billion in upfront payments and ...

This time it’s Novartis. The two companies have announced an exclusive ... agreement that could potentially be worth over $2.7 billion with Indianapolis-based Eli Lilly, which is now building two ...